相关实验视频

Updated: Jul 6, 2025

Deciphering the Molecular Mechanism and Function of Pore-Forming Toxins Using Leishmania major

Deciphering the Molecular Mechanism and Function of Pore-Forming Toxins Using Leishmania major

Published on: October 28, 2022

LdCyPA减弱了MAPK通路,以帮助Leishmania donovani在宿主细胞中的免疫逃逸

Shuangshuang Yin¹, Jiao Li², Jianping Chen²

¹Department of Pathogenic Biology, West China School of Basic Medical Sciences and Forensic Medicine, Sichuan University, Chengdu, Sichuan, PR China.

|January 8, 2024

概括

内脏莱什曼病寄生虫L. donovani使用环素A (LdCypA) 来逃避宿主免疫力. 在巨细胞中过度表达LdCypA抑制M1反应并改变MAPK信号,帮助寄生虫生存.

科学领域:

寄生虫学的寄生虫学
免疫学免疫学免疫学
分子生物学分子生物学

背景情况:

内脏莱什曼病是一种被忽视的热带疾病,由L. donovani.
巨细胞是L. donovani生存的关键宿主细胞.
L. donovani Cyclophilin A (LdCypA) 对于寄生虫的繁殖至关重要,但其免疫逃避机制尚不清楚.

研究的目的:

研究LdCypA在宿主免疫控制中的作用.
了解 LdCypA 如何促进 L. donovani. 的细胞内免疫逃脱.

主要方法:

产生的巨细胞系过度表达LdCyPA.
在L. donovani感染后分析宿主免疫反应.
利用转录组测序和机械验证.

主要成果:

过度表达LdCypA降低了M1巨细胞和促炎细胞因子 (IL-12,IFN-γ,TNF-α,INOS) 的调节.
LdCypA促进了抗炎IL-4的分泌.
阻断了MAPK通路中的P38/JNK1/2酸化和增加了ERK酸化,促进了免疫逃逸.

结论:

通过操纵宿主免疫调节,LdCypA对L. donovani细胞内生存至关重要.
确定了一种针对宿主细胞免疫力的新型免疫逃生策略.
这些发现支持开发宿主导的抗寄生虫药物.

关键词:

免疫逃脱是为了逃脱免疫.在 LdCyPAPA 中使用.这就是MAPKK的意思.内脏莱什曼病 - 内脏莱什曼病

更多相关视频

In vivo Imaging of Transgenic Leishmania Parasites in a Live Host

In vivo Imaging of Transgenic Leishmania Parasites in a Live Host

Published on: July 27, 2010

Immunometabolic Circuits in Infection for Advancing Host Directed Therapies

Immunometabolic Circuits in Infection for Advancing Host Directed Therapies

Published on: September 13, 2024

相关概念视频

MAPK Signaling Cascades

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...